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64 Surgical resection of limited disease small cell lung cancer in the new era of
platinum chemotherapy: Its time has come
Malcolm V. Brock, MD, Craig M. Hooker, MPH, James E. Syphard, BS, William Westra, MD,
Li Xu, MS, Anthony J. Alberg, PhD, David Mason, MD, Stephen B. Baylin, MD,
James G. Herman, MD, Rex C. Yung, MD, Julie Brahmer, MD, Charles M. Rudin, MD, PhD,
David S. Ettinger, MD, and Stephen C. Yang, MD, Baltimore, Md
Surgery is not the current standard of care in treating SCLC. We report favorable 5-year
survivals for patients with surgically treated early stage SCLC after adjuvant platinum-based
chemotherapy.
73 Results of unilateral lung volume reduction surgery in patients with distinct
heterogeneity of emphysema between lungs
Tommaso C. Mineo, MD, Eugenio Pompeo, MD, Davide Mineo, MD, Paola Rogliani, MD,
Carlo Leonardis, MD, and Italo Nofroni, BS, Rome, Italy
In this study, respiratory function, exercise capacity, and quality of life were improved for as
long as 60 months after unilateral thoracoscopic lung volume reduction surgery. Heterogeneity
of emphysema between lungs assessed at visual radiologic classification correlated directly with
improvement at 36 months in FEV1.
80 Iloprost to improve surfactant function in porcine pulmonary grafts stored
for twenty-four hours in low-potassium dextran solution
Bernhard Gohrbandt, MD, Sebastian P. Sommer, MD, Stefan Fischer, MD, MSc,
Jens M. Hohlfeld, MD, Gregor Warnecke, MD, Axel Haverich, MD, and Martin Strueber, MD,
Hannover, Germany
The effects of iloprost as an additive to low-potassium dextran solution for lung preservation
were tested in a porcine left-sided single-lung transplant model in a randomized, blinded
fashion. Posttransplantation ischemia-reperfusion injury and surfactant function in lung grafts
were improved by iloprost. Iloprost may improve lung preservation in clinical lung
transplantation.
87 Effect of tumor size on prognosis in patients with non–small cell lung
cancer: The role of segmentectomy as a type of lesser resection
Morihito Okada, MD, PhD, Wataru Nishio, MD, PhD, Toshihiko Sakamoto, MD, PhD,
Kazuya Uchino, MD, Tsuyoshi Yuki, MD, Akio Nakagawa, MD, and Noriaki Tsubota, MD,
PhD, Hyogo, Japan
We examined the association of tumor size with surgical procedures and their outcomes in
1272 patients who underwent complete resection for non–small cell lung carcinoma. Tumor
size is an independent and significant prognostic factor and essential for choosing surgical
mode of treatment. Segmentectomy might be acceptable for tumors of 20 mm or less in
diameter with no nodal involvement.
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